Parkinson's inhaler trial halted early: what happened?
NCT ID NCT05979415
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 22 times
Summary
This study tested an inhaler called Staccato Apomorphine (AZ-009) to quickly relieve 'OFF' episodes in people with Parkinson's disease—times when symptoms return between medication doses. The trial planned to include patients who had daily OFF episodes, but it was terminated early after enrolling only 8 participants. The goal was to measure symptom improvement using a standard Parkinson's rating scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accellacare of Piedmont Healthcare
Statesville, North Carolina, 28265, United States
-
Bradenton Research Center, Inc.
Bradenton, Florida, 34205, United States
-
CenExel iResearch Atlanta (Decatur)
Decatur, Georgia, 30030, United States
-
Cenexel Rocky Mountain Clinical Research
Englewood, Colorado, 80113, United States
-
Holy Cross Health
Fort Lauderdale, Florida, 33308, United States
-
KCA Neurology, (Part of Ki Health Partners, LLC)
Franklin, Tennessee, 37067, United States
-
Lone Star Neurology, (Part of Ki Health Partners, LLC)
Frisco, Texas, 75035, United States
-
Movement Disorders Center of Arizona
Scottsdale, Arizona, 85258, United States
-
Parkinson's Disease Treatment Center of Southwest Florida
Port Charlotte, Florida, 33980, United States
-
Quest Research Institute
Farmington Hills, Michigan, 48334, United States
-
The Parkinson's and Movement Disorder Institute
Fountain Valley, California, 92708, United States
-
Tuscon Neuroscience Research (M3 Wake Research)
Tucson, Arizona, 85710, United States
-
Visionary Investigators Network
Miami, Florida, 33133, United States
Conditions
Explore the condition pages connected to this study.